Transgene Statements
52
Transgene Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
0.9
100
0.004
0.4
0.896
99.6
—
0
1.532
170.2
5.114
568.2
-4.218
-468.7
-0.646
-71.8
0.95
105.6
-3.914
-434.9
—
0
-3.914
-434.9
-0.068
58.262
1.449
100
0.001
0.3
1.447
99.7
—
0
1.579
176.3
4.393
420
-2.946
-320.3
-0.646
-71.7
0.877
97.4
-2.714
-294.6
—
0
-2.714
-294.6
-0.04
67.862
—
100
0.651
0
-0.651
0
—
0
1.546
0
27.827
0
-28.478
0
-0.907
0
0.877
0
-28.508
0
—
0
-28.508
0
-0.375
75.994
0.551
100
0.012
0
0.539
0
—
0
1.492
0
32.087
0
-31.548
0
-0.907
0
0.877
0
-31.578
0
—
0
-31.578
0
-0.41
77.031
0.85
100
-0.555
-80.9
1.405
180.9
—
0
1.568
92.8
53.402
3203.9
-51.998
-3023
-1.134
-66.7
1.248
95.3
-51.883
-2994.4
—
0
-51.883
-2994.4
-0.684
75.834
0.017
100
0.093
186.7
-0.076
-86.7
—
0
1.311
3863
51.813
152744
-51.889
-152830.6
-1.134
-3344.8
0.877
2586.8
-52.146
-153588.6
—
0
-52.146
-153588.6
-0.688
75.77
1.696
100
0.471
312.5
1.225
-212.5
—
0
0.975
245.7
52.928
20321.3
-51.704
-20533.8
-1.331
-512.06
1.792
985.7
-51.243
-20060.2
—
0
-51.243
-20060.2
-0.676
75.77
—
100
0.137
0
-0.137
0
—
0
1.484
0
52.512
0
-52.649
0
-1.331
0
0.877
0
-53.104
0
—
0
-53.104
0
-0.703
75.555
0.036
100
-0.26
-883.8
0.296
983.8
—
0
1.429
1999.1
54.117
77966
-53.821
-76982.2
-1.503
-2102.2
0.841
1126.5
-54.483
-77957.8
—
0
-54.483
-77957.8
-0.718
75.881
—
100
0.408
0
-0.408
0
—
0
1.467
0
53.377
0
-53.785
0
-2.302
0
0.948
0
-55.139
0
—
0
-55.139
0
-0.727
75.838